Balyasny Asset Management
CLB icon

Balyasny Asset Management’s Core Laboratories CLB Stock Holding History

Balyasny Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,063
Closed -$161K – 3140
2025
Q3 		$161K Sell
13,063
-37,800
-74% -$443K ﹤0.01% 2752
2025
Q2 		$586K Buy
+50,863
New +$603K ﹤0.01% 2226
2024
Q3 		– Sell
-28,608
Closed -$580K – 2784
2024
Q2 		$580K Buy
+28,608
New +$506K ﹤0.01% 1999
2024
Q1 		– Sell
-12,340
Closed -$218K – 2675
2023
Q4 		$218K Sell
12,340
-6,668
-35% -$134K ﹤0.01% 2288
2023
Q3 		$456K Buy
+19,008
New +$467K ﹤0.01% 1781
2022
Q4 		– Sell
-36,785
Closed -$496K – 2823
2022
Q3 		$496K Sell
36,785
-44,497
-55% -$750K ﹤0.01% 2043
2022
Q2 		$1.61M Buy
81,282
+39,125
+93% +$1.04M 0.01% 1524
2022
Q1 		$1.33M Buy
42,157
+17,480
+71% +$490K ﹤0.01% 1547
2021
Q4 		$551K Buy
24,677
+1,127
+5% +$29.4K ﹤0.01% 1598
2021
Q3 		$654K Buy
23,550
+8,081
+52% +$246K ﹤0.01% 1430
2021
Q2 		$603K Sell
15,469
-16,774
-52% -$601K ﹤0.01% 1486
2021
Q1 		$928K Buy
32,243
+16,581
+106% +$566K ﹤0.01% 1285
2020
Q4 		$415K Buy
+15,662
New +$320K ﹤0.01% 1148
2019
Q2 		– Sell
-20,039
Closed -$1.38M – 1500
2019
Q1 		$1.38M Buy
20,039
+16,626
+487% +$1.11M 0.01% 928
2018
Q4 		$204K Buy
+3,413
New +$295K ﹤0.01% 1298
2015
Q3 		– Sell
-89,871
Closed -$10.2M – 1167
2015
Q2 		$10.2M Buy
+89,871
New +$10.9M 0.06% 384

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Balyasny Asset Management's CLB Position: Q4 2025 in Review

Balyasny Asset Management sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 13,063 shares — an estimated $161K sold.

Balyasny Asset Management first reported a position in CLB in Q2 2015 and held it in 16 quarters. The position peaked at $10.2M in Q2 2015. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Balyasny Asset Management reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 13,063 Core Laboratories shares in Q4 2025, an estimated $161K.
  • Balyasny Asset Management first reported a position in Core Laboratories in Q2 2015 and held it in 16 quarters.
  • Balyasny Asset Management's Core Laboratories position peaked at $10.2M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.